a patient with igg3 lambda plasma cell myeloma characterized by anemia , hypercalcemia , hypoalbuminemia , renal insufficiency , osteolytic bone lesions , and serum and urinary light chains inadvertently received a dose of intravenous melphalan considerably greater than standard .
C0026764
plasma cell myeloma
C0025241
melphalan